Treatment of organ transplant-related lymphoma

Research output: Contribution to journalArticle

Abstract

First described in organ transplant recipients in 1968, post-transplant lymphoproliferative disorder (PTLD) remains an often devastating complication of immunosuppression. Similar, if not identical, Epstein-Barr virus (EBV)- associated B lymphoproliferations have since been described in congenital and other acquired immunodeficiency states. Although PTLD is often morphologically indistinguishable from aggressive non-Hodgkin's lymphoma, the pathogenesis, presentation, clinical course, and management options differ significantly from those of classic NHL.

Original languageEnglish (US)
Pages (from-to)963-973
Number of pages11
JournalHematology/Oncology Clinics of North America
Volume11
Issue number5
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Treatment of organ transplant-related lymphoma'. Together they form a unique fingerprint.

  • Cite this